Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Elbur, Abubaker IbrahimGhebremichael, Musie
Konkle-Parker, Deborah
Jones, Deborah L.
Collins, Shelby
Adimora, Adaora A.
Schneider, Michael F.
Cohen, Mardge H.
Tamraz, Bani
Plankey, Michael
Wilson, Tracey
Adedimeji, Adebola
Haberer, Jessica
Jacobson, Denise L.
Journal title
JAIDS Journal of Acquired Immune Deficiency SyndromesDate Published
2023-02-13Publication Volume
93Publication Issue
2Publication Begin page
162Publication End page
170
Metadata
Show full item recordAbstract
Background: Women with HIV (WHIV) in the United States face many challenges with adherence to antiretroviral therapy (ART), and suboptimal adherence often leads to virologic failure. This study aimed to determine the association between ART adherence trajectories and the risk of virologic failure. Methods: We included WHIV (aged 18 years or older) enrolled in the Women's Interagency HIV Study in the United States from April 2014 to September 2019 who had at least 2 consecutive measurements of HIV RNA and ≥3 measurements of self-reported adherence. Group-based trajectory modeling was used to identify adherence trajectories. Cox proportional hazard ratios were used to measure the association. Main outcome measure: Virologic failure was defined as HIV RNA ≥200 copies/mL at 2 consecutive visits. Results: We included 1437 WHIV (median age 49 years). Of all women, 173 (12.0%) experienced virologic failure. Four adherence trajectories were identified, namely "consistently high" (26.3%), "moderate increasing" (9.5%), "moderate decreasing" (30.6%), and "consistently low" (33.5%). Women in the consistently low adherence group consumed alcohol and experienced depression more than other groups. Compared with the "consistently high" trajectory, the risk of virologic failure was higher among women with "consistently low" [adjusted hazard ratio (aHR) 2.8; 95% confidence interval (CI): 1.6 to 4.9; P < 0.001] and "moderate decreasing" adherence trajectories (aHR 1.8; 95% CI: 1.0 to 3.2; P = 0.04), but it was similar to those with "moderate increasing" adherence trajectory (aHR 1.0; 95% CI: 0.4 to 2.5; P = 0.94). Conclusions: Adherence to ART remains a challenge among WHIV. Multilevel behavioral interventions to address poor adherence, alcohol consumption, and depression are needed.Citation
Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, Collins S, Adimora AA, Schneider MF, Cohen MH, Tamraz B, Plankey M, Wilson T, Adedimeji A, Haberer J, Jacobson DL. Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States. J Acquir Immune Defic Syndr. 2023 Jun 1;93(2):162-170. doi: 10.1097/QAI.0000000000003174. Epub 2023 Feb 13. PMID: 36804871; PMCID: PMC10180014.DOI
10.1097/qai.0000000000003174ae974a485f413a2113503eed53cd6c53
10.1097/qai.0000000000003174
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International